The AU-rich element mRNA decay-promoting activity of BRF1 is regulated by mitogen-activated protein kinase-activated

Sushmit Maitra1, Chu-Fang Chou, Christian A Luber

  • 1Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.

RNA (New York, N.Y.)
|March 8, 2008
PubMed

Insights

MAPK-activated protein kinase 2 (MK2) directly phosphorylates BRF1, inhibiting its role in AU-rich element-mediated mRNA decay (AMD). This phosphorylation event regulates gene expression by controlling mRNA stability.

Area of Science:

  • Molecular Biology
  • Gene Expression Regulation
  • RNA Metabolism

Background:

  • Regulated mRNA decay is crucial for controlling gene expression.
  • AU-rich elements (AREs) in 3' untranslated regions target mRNAs for rapid decay via ARE-binding proteins (ARE-BPs).
  • Signaling pathways are known to regulate ARE-containing mRNA decay, likely by targeting ARE-BPs.

Purpose of the Study:

  • To investigate the role of MAPK-activated protein kinase 2 (MK2) in AU-rich element-mediated mRNA decay (AMD).
  • To determine if MK2 directly interacts with and modifies BRF1, a key protein in AMD.
  • To elucidate the mechanism by which MK2 influences BRF1 activity and subsequent mRNA decay.

Main Methods:

  • In vitro kinase assays using BRF1 fragments to identify phosphorylation sites.
  • Coexpression studies to assess the effect of active MK2 on BRF1's mRNA decay activity.
  • Analysis of BRF1's interaction with AREs and mRNA decay enzymes following MK2 phosphorylation.

Main Results:

  • MK2 directly phosphorylates BRF1 at four distinct sites, including S54, S92, and S203.
  • Active MK2 significantly inhibits BRF1's ARE-mediated mRNA decay activity.
  • MK2-mediated inhibition of BRF1 is dependent on phosphorylation at S54, S92, and S203, and does not affect RNA binding or association with decay enzymes.

Conclusions:

  • MK2 directly phosphorylates BRF1, leading to the inhibition of BRF1-dependent AMD.
  • The inhibitory mechanism appears to act downstream of RNA binding and enzyme recruitment.
  • MK2 represents a key regulatory point in controlling gene expression through modulation of mRNA stability.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.